A detailed history of Harbor Capital Advisors, Inc. transactions in Glaukos Corp stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 24,539 shares of GKOS stock, worth $3.84 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
24,539
Holding current value
$3.84 Million
% of portfolio
0.16%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 10, 2025

BUY
$126.42 - $152.67 $3.1 Million - $3.75 Million
24,539 New
24,539 $3.68 Million
Q4 2023

Jan 08, 2024

BUY
$59.53 - $85.11 $412,066 - $589,131
6,922 Added 33.96%
27,306 $2.17 Million
Q3 2023

Oct 20, 2023

BUY
$69.23 - $79.09 $317,142 - $362,311
4,581 Added 28.99%
20,384 $1.53 Million
Q2 2023

Jul 11, 2023

BUY
$45.44 - $71.21 $718,088 - $1.13 Million
15,803 New
15,803 $1.13 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.45B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Harbor Capital Advisors, Inc. Portfolio

Follow Harbor Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.